TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06634849: A Modular, Open Label, Dose Finding, Phase 1/2 Clinical Trial in Patients With Solid Tumours to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of PTT-4256.

Sponsor: Pathios Therapeutics Pty Ltd · Phase: PHASE1/PHASE2 · Area: ONCOLOGY · Target Enrollment: 30 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$8,246,700

Rescue Site Savings

+$5,458,530

Unlock Full NCT06634849 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06634849 Rescue Dossier →